United States · 
Who invested in BreezeBio?
BreezeBio's investors include Sequoia Capital, National Science Foundation, Qiming Venture Partners and Eli Lilly.
United States · Series B startup
Who invested in BreezeBio
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2026, from 1 source
- Latest round
- Series B, $60MFeb 2026
- Investors
- 4
The rounds
- Feb 2026Series B$60M
Source recorded
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list BreezeBio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about BreezeBio
How much has BreezeBio raised?
BreezeBio has raised $60M across 1 round since 2026.
When did BreezeBio last raise?
BreezeBio's most recent round was a Series B of $60M in Feb 2026.
What was BreezeBio's biggest round?
Its most recent round, $60M in Feb 2026, is also its largest on record.
Who backed BreezeBio first?
BreezeBio's first round on record, in Feb 2026, was backed by Sequoia Capital, National Science Foundation and Qiming Venture Partners and 1 others.
What stage is BreezeBio at?
BreezeBio's latest named round is a Series B, in Feb 2026.
Where is BreezeBio based?
BreezeBio is based in the United States.
Companies like BreezeBio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.